Annexon

-$1.25 (-5.68%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annexon and other ETFs, options, and stocks.

About ANNX

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy.

CEO
Douglas Love
Employees
48
Headquarters
South San Francisco, California
Founded
2011

ANNX Key Statistics

Market Cap
795.40M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
196.74K
High Today
$21.87
Low Today
$20.56
Open Price
$21.66
Volume
158.57K
52 Week High
$38.01
52 Week Low
$15.52

ANNX Earnings

-$28.87
-$19.25
-$9.62
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure